HIGHLIGHTS
- who: Andreas Venizelos from the of Clinical Science, University of Bergen, Bergen, Norway have published the Article: Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy, in the Journal: (JOURNAL) of November/19,/2007
- what: The authors aimed to assess the dynamic changes in subclonal composition of treatment-naïve cancers during Methods: All tissue samples in this study were collected as dictated by the DDP trial protocol. The authors aimed at assessing clonal evolution in treatment-naïve breast cancers during neoadjuvant chemotherapy. In the present analysis, TP53 mutations were not . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.